China Sky One Medical, Inc. Research Center Recognized by Heilongjiang Science and Technology... ( HARBIN China June 19 /Xinhua-- Ch...)

China Sky One Medical, Inc. Research Center Recognized by Heilongjiang Science and Technology Institute

Date:6/19/2008

HARBIN, China, June 19 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (Amex: CSY) ("China Sky One" or "the Company"), a China-based manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic kit products, announced today that its wholly-owned subsidiary, Harbin First Bio-Engineering Pharmaceutical Company, was recognized as an advanced research and development center by the Science and Technology Institute of Heilongjiang ("the Institute") in China on June 13, 2008.

The Institute is a government supported entity that promotes the development of high technology companies and technologically advanced products. The Institute will provide Harbin First Bio-Engineering Pharmaceutical Company subsidiary with the title "Disease Kits Technology Research and Development Center" as well as additional support and benefits, including a permanent 15% tax on the sale of new products (the normal tax is 25%), and a subsidy of RMB 2 million for 5 years.

Harbin First Bio-Engineering Pharmaceutical Company is the only research and development center for external use disease testing kits in Heilongjiang Province. Disease testing kits are used for the early detection of diseases. They require users to place a blood or urine sample on a marker and a positive (+) or negative (-) signal will result, showing whether he or she should consult a doctor for further testing.

"China Sky One is honored to receive this prestigious award for its research and development ability from the Science and Technology Institute of Heilongjiang," said Mr. Yan-qing Liu, Chairman, CEO and President of China Sky One Medical, Inc. "We will continue to improve our technology and research and development capabilities, and expect to
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI

Post Your Comments:

China Sky One Medical, Inc. Research Center Recognized by Heilongjiang Science and Technology...( HARBIN China June 19 /Xinhua-- Ch...),Health